Lily F Hoffman1, Neferterneken K Francis1, Marina Catallozzi2, Jenny K R Francis3, Lawrence R Stanberry3, Susan L Rosenthal4. 1. Department of Pediatrics, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York. 2. Department of Pediatrics, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York; NewYork-Presbyterian Hospital/Morgan Stanley Children's Hospital, New York, New York; Heilbrunn Department of Population and Family Health, Mailman School of Public Health, Columbia University Medical Center, New York, New York. 3. Department of Pediatrics, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York; NewYork-Presbyterian Hospital/Morgan Stanley Children's Hospital, New York, New York. 4. Department of Pediatrics, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York; NewYork-Presbyterian Hospital/Morgan Stanley Children's Hospital, New York, New York; Department of Psychiatry, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York. Electronic address: slr2154@columbia.edu.
Abstract
PURPOSE: Despite their heightened risk of sexually transmitted infections, minor adolescents (<18 years old) are often excluded from clinical trials. The results of trials of adults should not be assumed to generalize to minors. METHODS: Two public clinical trial registries were first searched using microbicide or PrEP with STD, STI, HIV, or HSV and with gel, ring, or film, and then searched using prevention/sexually transmitted diseases with gel. Studies were classified based on the information provided in the registry. RESULTS: The searches yielded 111 unique studies. Only 9.0% (n = 10) included minors. They were under-represented in Phase 0-II studies and over-represented in studies of individuals infected with human immunodeficiency virus. CONCLUSIONS: Minor adolescents should be included during all stages of development and before they have acquired an infection. Future studies should examine the challenges of including minor adolescents in trials and how to overcome these barriers.
PURPOSE: Despite their heightened risk of sexually transmitted infections, minor adolescents (<18 years old) are often excluded from clinical trials. The results of trials of adults should not be assumed to generalize to minors. METHODS: Two public clinical trial registries were first searched using microbicide or PrEP with STD, STI, HIV, or HSV and with gel, ring, or film, and then searched using prevention/sexually transmitted diseases with gel. Studies were classified based on the information provided in the registry. RESULTS: The searches yielded 111 unique studies. Only 9.0% (n = 10) included minors. They were under-represented in Phase 0-II studies and over-represented in studies of individuals infected with human immunodeficiency virus. CONCLUSIONS: Minor adolescents should be included during all stages of development and before they have acquired an infection. Future studies should examine the challenges of including minor adolescents in trials and how to overcome these barriers.
Authors: Christine Grady; Lori Wiener; Emily Abdoler; Emily Trauernicht; Sima Zadeh; Douglas S Diekema; Benjamin S Wilfond; David Wendler Journal: J Adolesc Health Date: 2014-03-14 Impact factor: 5.012
Authors: Irma M Hein; Pieter W Troost; Robert Lindeboom; Marc A Benninga; C Michel Zwaan; Johannes B van Goudoever; Ramón J L Lindauer Journal: JAMA Pediatr Date: 2014-12 Impact factor: 16.193
Authors: Jenny K R Francis; Lauren Dapena Fraiz; Ariel M de Roche; Marina Catallozzi; Carmen Radecki Breitkopf; Susan L Rosenthal Journal: J Empir Res Hum Res Ethics Date: 2017-12-10 Impact factor: 1.742
Authors: Jenny K R Francis; Ariel M de Roche; Christine Mauro; Sara E Landers; Jane Chang; Marina Catallozzi; Carmen Radecki Breitkopf; Susan L Rosenthal Journal: J Pediatr Adolesc Gynecol Date: 2018-06-12 Impact factor: 1.814
Authors: Marina Catallozzi; Ariel M de Roche; Mei-Chen Hu; Carmen Radecki Breitkopf; Jane Chang; Lisa S Ipp; Jenny K R Francis; Susan L Rosenthal Journal: J Pediatr Adolesc Gynecol Date: 2016-07-02 Impact factor: 1.814
Authors: Rebecca K Tsevat; Carmen Radecki Breitkopf; Sara E Landers; Ariel M de Roche; Christine Mauro; Lisa S Ipp; Marina Catallozzi; Susan L Rosenthal Journal: J Empir Res Hum Res Ethics Date: 2018-08-13 Impact factor: 1.742
Authors: Amelia Knopf; Claire Burke Draucker; J Dennis Fortenberry; Daniel H Reirden; Renata Arrington-Sanders; John Schneider; Diane Straub; Rebecca Baker; Giorgos Bakoyannis; Gregory D Zimet; Mary A Ott Journal: JMIR Res Protoc Date: 2020-03-30